Suppr超能文献

套细胞淋巴瘤缺乏细胞周期蛋白依赖性激酶抑制剂p27Kip1的表达。

Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor.

作者信息

Quintanilla-Martinez L, Thieblemont C, Fend F, Kumar S, Pinyol M, Campo E, Jaffe E S, Raffeld M

机构信息

Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

Am J Pathol. 1998 Jul;153(1):175-82. doi: 10.1016/S0002-9440(10)65558-7.

Abstract

p27Kip1 is a cyclin-dependent kinase inhibitor that regulates the decision to enter S phase or withdraw from the cell cycle. In resting cells, the level of p27Kip1 provides an inhibitory threshold above which G1 cyclin D/E/cyclin-dependent kinases accumulate before activation; however, in cycling cells, p27Kip1 protein is sequestered by high levels of active cyclin D/cyclin-dependent kinase 4 complexes. As a group, the cyclin-dependent kinase inhibitors have been proposed to act as tumor suppressor genes, and several members have been implicated in the pathogenesis of a variety of human cancers. We examined p27Kip1 expression in 116 non-Hodgkin's lymphomas including 50 cases of MCL (40 typical and 10 blastic variants), 21 follicular lymphomas, 20 diffuse large B-cell lymphomas, 16 chronic lymphocytic leukemias, 8 marginal zone B-cell lymphomas, and 1 splenic marginal zone lymphoma, and correlated its expression with that of the proliferation marker Ki67 (MiB1) and with p53. p27Kip1 gene structure was analyzed by Southern blot in the group of MCLs. In all cases of non-Hodgkin's lymphoma other than MCL, p27Kip1 expression was inversely related to the proliferation index as measured by Ki67. In contrast, in typical MCL, p27Kip1 expression was negative in 35 of 40 (88%) cases, irrespective of the proliferative rate (median 15%; range 2 to 90%). Paradoxically, in the blastic variant of MCL, 8 of 10 (80%) cases showed expression of p27Kip1, despite a high proliferation rate (median 60%; range 32 to 100%). However, the staining in most of the cases was less intense than in the reactive T lymphocytes. Deletions of p27Kip1 gene were not found in any of the 25 cases examined. p53 expression was found in 15 of 50 cases of MCL: 7 of 10 (70%) in the blastic variant and 8 of 40 (20%) in the typical MCL (70% vs. 20%, P < 0.0045). These results demonstrate that MCLs, in contrast to other non-Hodgkin's lymphomas and normal lymphoid tissue, fail to correlate p27Kip1 expression with the proliferation rate. This peculiar uncoupling of p27Kip1 protein expression from the proliferation rate may be related to the high levels of cyclin D1 expressed in MCL and is likely to have profound effects on cell cycle regulation and contribute to the pathogenesis of MCL.

摘要

p27Kip1是一种细胞周期蛋白依赖性激酶抑制剂,可调节进入S期或退出细胞周期的决定。在静止细胞中,p27Kip1的水平提供了一个抑制阈值,高于该阈值,G1期细胞周期蛋白D/E/细胞周期蛋白依赖性激酶在激活前积累;然而,在循环细胞中,p27Kip1蛋白被高水平的活性细胞周期蛋白D/细胞周期蛋白依赖性激酶4复合物隔离。作为一个整体,细胞周期蛋白依赖性激酶抑制剂被认为是肿瘤抑制基因,并且一些成员与多种人类癌症的发病机制有关。我们检测了116例非霍奇金淋巴瘤中p27Kip1的表达,包括50例套细胞淋巴瘤(40例典型型和10例母细胞变型)、21例滤泡性淋巴瘤、20例弥漫性大B细胞淋巴瘤、16例慢性淋巴细胞白血病、8例边缘区B细胞淋巴瘤和1例脾边缘区淋巴瘤,并将其表达与增殖标志物Ki67(MiB1)和p53的表达进行了关联分析。通过Southern印迹法分析了套细胞淋巴瘤组中的p27Kip1基因结构。在除套细胞淋巴瘤外的所有非霍奇金淋巴瘤病例中,p27Kip1表达与通过Ki67测量的增殖指数呈负相关。相比之下,在典型套细胞淋巴瘤中,40例中有35例(88%)p27Kip1表达为阴性,与增殖率无关(中位数为15%;范围为2%至90%)。矛盾的是,在套细胞淋巴瘤的母细胞变型中,10例中有8例(80%)显示p27Kip1表达,尽管增殖率很高(中位数为60%;范围为32%至100%)。然而,大多数病例中的染色强度低于反应性T淋巴细胞。在所检测的25例病例中均未发现p27Kip1基因缺失。在50例套细胞淋巴瘤病例中有15例发现p53表达:母细胞变型中10例中有7例(70%),典型套细胞淋巴瘤中40例中有8例(20%)(70%对20%,P<0.0045)。这些结果表明,与其他非霍奇金淋巴瘤和正常淋巴组织相比,套细胞淋巴瘤未能使p27Kip1表达与增殖率相关联。p27Kip1蛋白表达与增殖率这种特殊的解偶联可能与套细胞淋巴瘤中高水平表达的细胞周期蛋白D1有关,并且可能对细胞周期调节产生深远影响并有助于套细胞淋巴瘤的发病机制。

相似文献

引用本文的文献

1
Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma.进行性套细胞淋巴瘤中CCN1、p21和p27的分子特征
J Cell Commun Signal. 2019 Sep;13(3):421-434. doi: 10.1007/s12079-018-0494-y. Epub 2018 Nov 21.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验